Remote Patient Monitoring Market 2026 | Size, Share, Growth, Trends and Forecast

Remote Patient Monitoring Market Overview:

The United States accounts for a significant share of the global remote patient monitoring (RPM) market. The U.S. RPM market alone is projected to represent an opportunity exceeding $18 billion by 2026, growing at a robust CAGR of approximately 25% between 2021 and 2026. This growth is being fueled by the rising prevalence of chronic diseases, the introduction of new CMS reimbursement and CPT codes, the pandemic-driven shift of care delivery from hospitals to home settings, and rapid advancements in RPM hardware, software, and clinical care capabilities.

Year-End Mega Sale: Get Up to 10% Off on All Market Research Reports!

According to Medi-Tech Insight’s latest analysis, the global remote patient monitoring market presents substantial, largely untapped growth potential. The report provides an in-depth examination of key growth drivers, pricing dynamics, the competitive landscape, segment-level analysis, product and offering mapping, and emerging white-space opportunities.

Healthcare is evolving rapidly, driven by continuous technological innovation and expanding service models. One of the most impactful developments is remote patient monitoring, which offers meaningful advantages in a world facing an aging population and a growing burden of chronic illnesses. Advances in communication and sensor technologies now enable patient monitoring not only within hospital environments but also in home settings. Modern RPM solutions can track multiple vital parameters, including blood pressure, heart rate, respiratory rate, ECG readings, temperature, and blood glucose levels. These technologies are increasingly used to monitor diverse patient groups, such as individuals with chronic conditions, accident victims, elderly patients, and premature infants.

Key Influencing Factors in the Global Remote Patient Monitoring Market

Growth Drivers

• Introduction of CMS-approved expanded CPT codes for Remote Therapeutic Monitoring (RTM) in 2022 (98975, 98976, 98977, 98980, and +98981), enabling reimbursement for monitoring and interpretation of non-physiological data related to respiratory and musculoskeletal systems, therapy adherence, and treatment response.
• Earlier rollout of RPM CPT reimbursement codes in 2019 (99453, 99454, 99457) and 2020 (99458), which significantly accelerated adoption of RPM services.
• Increasing prevalence of chronic diseases and mounting pressure to reduce overall healthcare costs.
• Growing recognition of RPM as a proactive care tool that improves patient engagement while reducing emergency department visits, hospital readmissions, and lengths of stay.
• Presence of more than 200 small and mid-sized companies, fostering competition, innovation, and market expansion.
• A favorable investment climate supporting RPM and telehealth solutions.

Market Barriers and Challenges

• Continuous data monitoring poses challenges for clinicians, including alert fatigue and the burden of 24/7 data review.
• Patient readiness and data privacy concerns, particularly among older and less tech-savvy populations.
• Difficulties integrating third-party RPM data seamlessly into existing electronic health record (EHR) systems.

Download Sample: https://meditechinsights.com/remote-patient-monitoring-market/request-sample/

Impact of COVID-19 on the RPM Market

The COVID-19 pandemic significantly accelerated adoption of remote patient monitoring, highlighting its value in maintaining continuity of care while minimizing exposure risks. The next phase of market growth is expected to be driven by sustained adoption during and beyond the pandemic, increased demand for cost-effective care models, and improved outcomes for patients with chronic conditions. Financial incentives and patient demand are also boosting post-acute care adoption, particularly in specialties such as cardiology and orthopedics.

User Segments and Market Structure

While healthcare providers remain the largest users of RPM solutions, other high-growth segments—including health plans and payors, employers, home health agencies, and clinical trial organizations—are expected to expand rapidly over the next five years.

The global RPM market is highly fragmented, with over 200 companies competing in this emerging space. This fragmentation underscores the importance of well-defined pricing strategies and effective go-to-market approaches. Companies from adjacent sectors, such as telehealth and personal emergency response systems (PERS), are also entering the RPM market, as evidenced by major acquisitions like Teladoc’s acquisition of Livongo.

Key Growth Strategies for RPM Companies

• Developing comprehensive, integrated solutions tailored to specific chronic conditions such as diabetes, COPD, and hypertension.
• Leveraging AI and machine learning to enhance patient engagement, adherence, and outcomes.
• Moving beyond data collection to enable population health management for providers.
• Forming partnerships with technology vendors, device manufacturers, and care delivery organizations to create end-to-end care pathways.
• Pursuing strategic mergers and acquisitions to expand geographic reach, disease coverage, and operational scale.

Business Models and Competitive Landscape

The subscription-based model remains the most prevalent business model in the RPM market. Under this approach, RPM vendors provide devices and software platforms to healthcare providers, who then deploy these solutions to patients for ongoing remote monitoring.

The competitive landscape includes both established players and emerging companies. Key participants in the global RPM market include Vivify Health, Health Recovery Solutions, Teladoc–Livongo, Amwell, AMC Health, Careclix, Ontrak, Accuhealth, iHealth Labs, and others. Many innovative companies are differentiating themselves by refining business models, enhancing product and service offerings, and tailoring pricing strategies based on customer segment, geographic reach, population health metrics, and the continuum of care addressed.

Browse Report: https://meditechinsights.com/remote-patient-monitoring-market/

Future Outlook

The outlook for the global remote patient monitoring market remains highly promising. Continued investments in RPM and telehealth, increased emphasis on post-acute and home-based care, advancements in technology and artificial intelligence, a growing elderly population, and the entry of new market players are expected to drive sustained growth. Key benefits of RPM—including reduced infection risk, faster access to patient data, improved outcomes, optimized use of healthcare resources, and cost savings—will further support market expansion.

Today represents a unique window of opportunity for stakeholders to capitalize on this high-growth market by adopting the right strategies and leveraging deep industry expertise.

Related Report:

• HPV Testing and PAP Test Market https://www.pharmiweb.com/press-release/2025-12-18/hpv-testing-and-pap-test-market-share-size-growth-forecast-till-2030
• Cellular Health Screening Market https://www.pharmiweb.com/press-release/2025-12-18/cellular-health-screening-market-2030-analysis-size-share-growth-trends-and-forecast
• Hematology Market https://www.pharmiweb.com/press-release/2025-12-18/hematology-market-outlook-2030-industry-trends-and-competitive-analysis
• Long-Term Care Software Market https://www.pharmiweb.com/press-release/2025-12-18/long-term-care-software-market-demand-for-evidence-based-medicine-and-research-updates

About Medi-Tech Insights;

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com